• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    1.60 0.00(0.00%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:1.60
    Open:1.59
    Bid:N/A
    Ask:11.00 x 10000
    1y Target Est:10.17
    Beta:1.97
    Next Earnings Date:N/A
    Day's Range:1.56 - 1.61
    52wk Range:1.40 - 6.84
    Volume:147,005
    Avg Vol (3m):217,436
    Market Cap:33.81M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXII 0.00%33.81M
    AGNUp 0.45%62.59B
    ALNYUp 1.05%7.19B
    MRNADown 5.11%16.74M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):393.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.90
    Quarterly EPS Est (Dec-14) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback